Discover the top gainers and worst losers in India's unlisted market from April 2022 to April 2025. From Orbis Financial’s stellar 468% return to PharmaEasy’s steep decline, this video reveals the hidden opportunities and risks of pre-IPO investing. Watch now to see which unlisted shares made history — and which ones taught tough lessons.
Discover the top gainers and worst losers in India's unlisted market from April 2022 to April 2025. From Orbis Financial’s stellar 468% return to PharmaEasy’s steep decline, this video reveals the hidden opportunities and risks of pre-IPO investing.
Watch now to see which unlisted shares made history — and which ones taught tough lessons.
